세계의 핵의학 사이클로트론 시스템 시장 : 분석 및 예측(2018-2029년)

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029.

Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Cyclotron Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Cyclotron Systems.

The Nuclear Medicine Cyclotron Systems market size, estimations, and forecasts are provided in terms of sales volume (Unit) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nuclear Medicine Cyclotron Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Cyclotron Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the Nuclear Medicine Cyclotron Systems segments by manufacturers, by Type, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2018-2022, 2023-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company

• GE Healthcare
• IBA
• Best Cyclotron Systems
• Advanced Cyclotron Systems (ACSI)
• Sumitomo Heavy Industries
• Longevous Beamtech

Segment by Type

• Cyclotron Less than 12 MeV
• Cyclotron 13-18 MeV
• Cyclotron 19-24 MeV
• Cyclotron More than 24 MeV

Segment by Application

• Pharmaceutical Industry
• Hospital
• Research & Academics

By Region

• North America
  • United States
  • Canada

• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Rest of Asia-Pacific

• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain

• Latin America
  • Brazil

• Middle East & Africa

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter Two: Detailed analysis of Nuclear Medicine Cyclotron Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Three: Sales, revenue of Nuclear Medicine Cyclotron Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.

Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Analysis of sales channel, distributors and customers.

Chapter Thirteen: Research Findings and Conclusion.

Table of Contents

1 Nuclear Medicine Cyclotron Systems Market Overview

• 1.1 Nuclear Medicine Cyclotron Systems Product Overview
• 1.2 Nuclear Medicine Cyclotron Systems Market by Type
  • 1.2.1 Cyclotron Less than 12 MeV
  • 1.2.2 Cyclotron 13-18 MeV
  • 1.2.3 Cyclotron 19-24 MeV
  • 1.2.4 Cyclotron More than 24 MeV
• 1.3 Global Nuclear Medicine Cyclotron Systems Market Size by Type
  • 1.3.1 Global Nuclear Medicine Cyclotron Systems Market Size Overview by Type (2018-2029)
  • 1.3.2 Global Nuclear Medicine Cyclotron Systems Historic Market Size Review by Type (2018-2023)
  • 1.3.3 Global Nuclear Medicine Cyclotron Systems Forecasted Market Size by Type (2024-2029)
• 1.4 Key Regions Market Size by Type
  • 1.4.1 North America Nuclear Medicine Cyclotron Systems Sales Breakdown by Type (2018-2023)
  • 1.4.2 Europe Nuclear Medicine Cyclotron Systems Sales Breakdown by Type (2018-2023)
  • 1.4.3 Asia-Pacific Nuclear Medicine Cyclotron Systems Sales Breakdown by Type (2018-2023)
  • 1.4.4 Latin America Nuclear Medicine Cyclotron Systems Sales Breakdown by Type (2018-2023)
  • 1.4.5 Middle East and Africa Nuclear Medicine Cyclotron Systems Sales Breakdown by Type (2018-2023)

2 Nuclear Medicine Cyclotron Systems Market Competition by Company

• 2.1 Global Top Players by Nuclear Medicine Cyclotron Systems Sales (2019-2023)
• 2.2 Global Top Players by Nuclear Medicine Cyclotron Systems Revenue (2019-2023)
• 2.3 Global Top Players by Nuclear Medicine Cyclotron Systems Price (2019-2023)
• 2.4 Global Top Manufacturers Nuclear Medicine Cyclotron Systems Manufacturing Base Distribution
• 2.5 Nuclear Medicine Cyclotron Systems Market Competitive Situation and Trends
  • 2.5.1 Nuclear Medicine Cyclotron Systems Market Concentration Rate (2019-2023)
  • 2.5.2 Global 3 and 5 Largest Manufacturers by Nuclear Medicine Cyclotron Systems Revenue in 2022
• 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Cyclotron Systems as of 2022)
• 2.7 Date of Key Manufacturers Enter into Nuclear Medicine Cyclotron Systems Market
• 2.8 Mergers & Acquisitions, Expansion

3 Nuclear Medicine Cyclotron Systems Status and Outlook by Region

• 3.1 Global Nuclear Medicine Cyclotron Systems Market Size and CAGR by Region: 2018 VS 2022 VS 2029
• 3.2 Global Nuclear Medicine Cyclotron Systems Historic Market Size by Region
  • 3.2.1 Global Nuclear Medicine Cyclotron Systems Sales in Volume by Region (2018-2023)
  • 3.2.2 Global Nuclear Medicine Cyclotron Systems Sales in Value by Region (2018-2023)
  • 3.2.3 Global Nuclear Medicine Cyclotron Systems Sales (Volume & Value), Price and Gross Margin (2018-2023)
• 3.3 Global Nuclear Medicine Cyclotron Systems Forecasted Market Size by Region
  • 3.3.1 Global Nuclear Medicine Cyclotron Systems Sales in Volume by Region (2024-2029)
  • 3.3.2 Global Nuclear Medicine Cyclotron Systems Sales in Value by Region (2024-2029)
  • 3.3.3 Global Nuclear Medicine Cyclotron Systems Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Nuclear Medicine Cyclotron Systems by Application

• 4.1 Nuclear Medicine Cyclotron Systems Market by Application
  • 4.1.1 Pharmaceutical Industry
  • 4.1.2 Hospital
  • 4.1.3 Research & Academics
• 4.2 Global Nuclear Medicine Cyclotron Systems Market Size by Application
  • 4.2.1 Global Nuclear Medicine Cyclotron Systems Market Size Overview by Application (2018-2029)
  • 4.2.2 Global Nuclear Medicine Cyclotron Systems Historic Market Size Review by Application (2018-2023)
  • 4.2.3 Global Nuclear Medicine Cyclotron Systems Forecasted Market Size by Application (2024-2029)
• 4.3 Key Regions Market Size by Application
  • 4.3.1 North America Nuclear Medicine Cyclotron Systems Sales Breakdown by Application (2018-2023)
  • 4.3.2 Europe Nuclear Medicine Cyclotron Systems Sales Breakdown by Application (2018-2023)
  • 4.3.3 Asia-Pacific Nuclear Medicine Cyclotron Systems Sales Breakdown by Application (2018-2023)
  • 4.3.4 Latin America Nuclear Medicine Cyclotron Systems Sales Breakdown by Application (2018-2023)
  • 4.3.5 Middle East and Africa Nuclear Medicine Cyclotron Systems Sales Breakdown by Application (2018-2023)

5 North America Nuclear Medicine Cyclotron Systems by Country

• 5.1 North America Nuclear Medicine Cyclotron Systems Historic Market Size by Country
  • 5.1.1 North America Nuclear Medicine Cyclotron Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
  • 5.1.2 North America Nuclear Medicine Cyclotron Systems Sales in Volume by Country (2018-2023)
  • 5.1.3 North America Nuclear Medicine Cyclotron Systems Sales in Value by Country (2018-2023)
• 5.2 North America Nuclear Medicine Cyclotron Systems Forecasted Market Size by Country
  • 5.2.1 North America Nuclear Medicine Cyclotron Systems Sales in Volume by Country (2024-2029)
  • 5.2.2 North America Nuclear Medicine Cyclotron Systems Sales in Value by Country (2024-2029)

6 Europe Nuclear Medicine Cyclotron Systems by Country

• 6.1 Europe Nuclear Medicine Cyclotron Systems Historic Market Size by Country
  • 6.1.1 Europe Nuclear Medicine Cyclotron Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
  • 6.1.2 Europe Nuclear Medicine Cyclotron Systems Sales in Volume by Country (2018-2023)
  • 6.1.3 Europe Nuclear Medicine Cyclotron Systems Sales in Value by Country (2018-2023)
• 6.2 Europe Nuclear Medicine Cyclotron Systems Forecasted Market Size by Country
  • 6.2.1 Europe Nuclear Medicine Cyclotron Systems Sales in Volume by Country (2024-2029)
  • 6.2.2 Europe Nuclear Medicine Cyclotron Systems Sales in Value by Country (2024-2029)

7 Asia-Pacific Nuclear Medicine Cyclotron Systems by Region

• 7.1 Asia-Pacific Nuclear Medicine Cyclotron Systems Historic Market Size by Region
  • 7.1.1 Asia-Pacific Nuclear Medicine Cyclotron Systems Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
  • 7.1.2 Asia-Pacific Nuclear Medicine Cyclotron Systems Sales in Volume by Region (2018-2023)
  • 7.1.3 Asia-Pacific Nuclear Medicine Cyclotron Systems Sales in Value by Region (2018-2023)
• 7.2 Asia-Pacific Nuclear Medicine Cyclotron Systems Forecasted Market Size by Region
  • 7.2.1 Asia-Pacific Nuclear Medicine Cyclotron Systems Sales in Volume by Region (2024-2029)
  • 7.2.2 Asia-Pacific Nuclear Medicine Cyclotron Systems Sales in Value by Region (2024-2029)

8 Latin America Nuclear Medicine Cyclotron Systems by Country

• 8.1 Latin America Nuclear Medicine Cyclotron Systems Historic Market Size by Country
  • 8.1.1 Latin America Nuclear Medicine Cyclotron Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
  • 8.1.2 Latin America Nuclear Medicine Cyclotron Systems Sales in Volume by Country (2018-2023)
  • 8.1.3 Latin America Nuclear Medicine Cyclotron Systems Sales in Value by Country (2018-2023)
• 8.2 Latin America Nuclear Medicine Cyclotron Systems Forecasted Market Size by Country
  • 8.2.1 Latin America Nuclear Medicine Cyclotron Systems Sales in Volume by Country (2024-2029)
  • 8.2.2 Latin America Nuclear Medicine Cyclotron Systems Sales in Value by Country (2024-2029)

9 Middle East and Africa Nuclear Medicine Cyclotron Systems by Country

• 9.1 Middle East and Africa Nuclear Medicine Cyclotron Systems Historic Market Size by Country
  • 9.1.1 Middle East and Africa Nuclear Medicine Cyclotron Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
  • 9.1.2 Middle East and Africa Nuclear Medicine Cyclotron Systems Sales in Volume by Country (2018-2023)
  • 9.1.3 Middle East and Africa Nuclear Medicine Cyclotron Systems Sales in Value by Country (2018-2023)
• 9.2 Middle East and Africa Nuclear Medicine Cyclotron Systems Forecasted Market Size by Country
  • 9.2.1 Middle East and Africa Nuclear Medicine Cyclotron Systems Sales in Volume by Country (2024-2029)
  • 9.2.2 Middle East and Africa Nuclear Medicine Cyclotron Systems Sales in Value by Country (2024-2029)

10 Company Profiles

• 10.1 GE Healthcare
  • 10.1.1 GE Healthcare Company Information
  • 10.1.2 GE Healthcare Introduction and Business Overview
  • 10.1.3 GE Healthcare Nuclear Medicine Cyclotron Systems Sales, Revenue and Gross Margin (2019-2023)
  • 10.1.4 GE Healthcare Nuclear Medicine Cyclotron Systems Products Offered
  • 10.1.5 GE Healthcare Recent Development
• 10.2 IBA Radiopharma Solutions
  • 10.2.1 IBA Radiopharma Solutions Company Information
  • 10.2.2 IBA Radiopharma Solutions Introduction and Business Overview
  • 10.2.3 IBA Radiopharma Solutions Nuclear Medicine Cyclotron Systems Sales, Revenue and Gross Margin (2019-2023)
  • 10.2.4 IBA Radiopharma Solutions Nuclear Medicine Cyclotron Systems Products Offered
  • 10.2.5 IBA Radiopharma Solutions Recent Development
• 10.3 Best Cyclotron Systems
  • 10.3.1 Best Cyclotron Systems Company Information
  • 10.3.2 Best Cyclotron Systems Introduction and Business Overview
  • 10.3.3 Best Cyclotron Systems Nuclear Medicine Cyclotron Systems Sales, Revenue and Gross Margin (2019-2023)
  • 10.3.4 Best Cyclotron Systems Nuclear Medicine Cyclotron Systems Products Offered
  • 10.3.5 Best Cyclotron Systems Recent Development
• 10.4 Advanced Cyclotron Systems (ACSI)
  • 10.4.1 Advanced Cyclotron Systems (ACSI) Company Information
  • 10.4.2 Advanced Cyclotron Systems (ACSI) Introduction and Business Overview
  • 10.4.3 Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems Sales, Revenue and Gross Margin (2019-2023)
  • 10.4.4 Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems Products Offered
• 10.5 Sumitomo Heavy Industries
  • 10.5.1 Sumitomo Heavy Industries Company Information
  • 10.5.2 Sumitomo Heavy Industries Introduction and Business Overview
  • 10.5.3 Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems Sales, Revenue and Gross Margin (2019-2023)
  • 10.5.4 Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems Products Offered
• 10.6 Longevous Beamtech
  • 10.6.1 Longevous Beamtech Company Information
  • 10.6.2 Longevous Beamtech Introduction and Business Overview
  • 10.6.3 Longevous Beamtech Nuclear Medicine Cyclotron Systems Sales, Revenue and Gross Margin (2019-2023)
  • 10.6.4 Longevous Beamtech Nuclear Medicine Cyclotron Systems Products Offered

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

• 11.1 Nuclear Medicine Cyclotron Systems Key Raw Materials
  • 11.1.1 Key Raw Materials
  • 11.1.2 Raw Materials Key Suppliers
• 11.2 Manufacturing Cost Structure
  • 11.2.1 Raw Materials
  • 11.2.2 Labor Cost
  • 11.2.3 Manufacturing Expenses
• 11.3 Nuclear Medicine Cyclotron Systems Industrial Chain Analysis
  • 11.3.1 Nuclear Medicine Cyclotron Systems Industry Trends
  • 11.3.2 Nuclear Medicine Cyclotron Systems Market Drivers
  • 11.3.3 Nuclear Medicine Cyclotron Systems Market Challenges
  • 11.3.4 Nuclear Medicine Cyclotron Systems Market Restraints

12 Marketing Strategy Analysis, Distributors

• 12.1 Sales Channel
• 12.2 Nuclear Medicine Cyclotron Systems Downstream Customers

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
  • 14.1.2 Data Source
• 14.2 Author Details
• 14.3 Disclaimer